20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Suplatast Tosilate: A Novel API for Managing Atopic Dermatitis

Atopic dermatitis, a chronic inflammatory skin condition, affects millions globally, causing intense itching, redness, and discomfort. Effective management often requires addressing the underlying allergic inflammation. Suplatast Tosilate, known by its CAS 94055-76-2, is emerging as a novel active pharmaceutical ingredient (API) offering promising dermatological solutions for this challenging condition.


This compound acts as a potent Th2 cytokine inhibitor, which is crucial in the pathophysiology of atopic dermatitis. By suppressing the production of inflammatory cytokines such as IL-4 and IL-5, and inhibiting IgE, Suplatast Tosilate directly interferes with the allergic cascade that drives skin inflammation and itching. This targeted mechanism of action provides relief by modulating the immune response, rather than merely suppressing symptoms, leading to more sustainable improvement for patients.


The role of Suplatast Tosilate in atopic dermatitis treatment is significant. It helps reduce eosinophil infiltration and chronic inflammation in the skin, contributing to skin barrier restoration and overall symptom alleviation. As an orally active immunoregulator, it offers a convenient and effective therapeutic option for long-term management of atopic dermatitis, enhancing patient adherence.


For pharmaceutical companies focused on dermatological solutions, sourcing high-quality APIs like Suplatast Tosilate is essential. NINGBO INNO PHARMCHEM CO.,LTD. is a trusted Suplatast Tosilate supplier, providing pharmaceutical raw material with assured purity (≥98%). Our commitment to quality ensures that drug manufacturers have access to the best ingredients for their innovative skin health products. We understand the specific needs for developing effective treatments for complex conditions like atopic dermatitis.


Considering the increasing demand for advanced therapies in dermatology, securing a reliable supply of Suplatast Tosilate is a strategic advantage. NINGBO INNO PHARMCHEM CO.,LTD. offers competitive pricing and dedicated support for those looking to buy Suplatast Tosilate API. Partner with us to develop next-generation solutions for atopic dermatitis and improve the lives of patients suffering from chronic skin conditions.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Optimizing API Sourcing: Suplatast Tosilate for Asthma and Rhinitis Medications

Next: Suplatast Tosilate: An Innovation in Antihistamine & Anti-inflammatory Drugs

All Rights Reserved